论文部分内容阅读
胃达喜是德国拜耳公司生产的第三代抗酸剂及胃粘膜细胞的保护剂,化学名为铝碳酸镁,临床上主要用于治疗非溃疡性消化不良(NUD),消化性溃疡及返流性食道炎等疾病。笔者于98年4月至8月,应用胃达喜治疗非溃疡性消化不良79例,并对57例本病患者采用硫糖铝片进行对照,旨在观察胃达喜治疗非溃疡性消化不良的疗效及其安全性,现将结果报告如下:1 一般资料 入选试验的患者年龄在20～65岁,入选前经临床和胃镜检查证实为NUD,试验前一周停用一切治疗胃部疾病的药物,所有患者愿意参加试验。胃达喜组79例,年龄45.2±5.5岁,男43例,女36例,硫糖铝组57例,年龄44.1±4.8岁,男34例,女23例,所有患者的主要症状为疼痛、烧心、暖气、腹胀、恶心等,两组病人年龄、、性别、主要症状相比无明显差异。
Gadda is Germany’s Bayer company produced the third generation of antacids and gastric mucosal cell protection agent, the chemical name of aluminum magnesium carbonate, clinically used mainly for the treatment of non-ulcer dyspepsia (NUD), peptic ulcer and the return Fluid esophagitis and other diseases. The author in April 98 to August, the application of Weida Xi treatment of non-ulcer dysplasia in 79 cases, and 57 cases of patients with sucralfate tablets for control purposes, to observe the treatment of non-ulcer dyspepsia The results are reported as follows: 1 General Information Patients enrolled in the trial were aged 20 to 65 years. Clinical and endoscopy confirmed NUD before enrollment. All drugs for the treatment of gastric diseases were discontinued one week prior to the trial All patients are willing to participate in the trial. Gadaxi group 79 cases, aged 45.2 ± 5.5 years, 43 males and 36 females, sucralfate group 57 cases, aged 44.1 ± 4.8 years, 34 males and 23 females, all patients with the main symptoms of pain, Heartburn, heating, bloating, nausea, etc. The two groups of patients age, sex, the main symptoms were no significant difference.